24 results on '"Male, C"'
Search Results
2. Bleeding phenotype according to factor level in 825 children with non-severe hemophilia; data from the PedNet cohort
3. Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
4. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
5. Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis
6. Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study
7. Anti‐activated factor II assay for monitoring unfractionated heparin in children: results of the HEARTCAT study
8. Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry
9. Inhibitor development and mortality in non‐severe hemophilia A
10. No impact of endogenous prothrombotic conditions on the risk of central venous line‐related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis)
11. Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues
12. Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma
13. The factor VIII treatment history of non-severe hemophilia A
14. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose vs. low‐dose heparin protocols
15. Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study
16. Efficacy, pharmacokinetics (PK) and safety results of a phase 3 clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated children with hemophilia B: OR346
17. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis: discussion
18. Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH
19. Hemophilia B Leyden: characteristics and natural history in the European Pediatric Network of Hemophilia Management Registry
20. Exploration of biomarkers for early recognition of FVIII inhibitor development in previously untreated severe hemophilia A patients: Hemophilia Inhibitor PUP Study and beyond: OC 22.1
21. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children
22. Randomized controlled trial comparing high-dose vs. low-dose heparinization protocols for prophylaxis of thrombotic complications during cc in children (HEARTCAT study): O-TH-137
23. Impact of persistent antiphospholipid antibodies on symptomatic thromboembolism in children: a systematic review & meta-analysis [observational studies]: O-WE-032
24. The presence of IgG antibodies against β2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.